Impact of GHK on Gene Regulation in COPD, Protein Clearance, and Neurological Pathways

by Dr. James Ross

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law.

GHK (glycyl-l-histidyl-l-lysine) is a naturally occurring copper-binding tripeptide that plays a restorative role in numerous biological processes. Its levels decline with aging, yet it has been shown to exert a wide spectrum of protective and regenerative effects. These include promoting wound repair, supporting tissue regeneration in skin, connective tissue, bone, and gastrointestinal lining, as well as stimulating hair follicle health. GHK increases collagen and decorin synthesis, enhances angiogenesis, and encourages neuronal outgrowth. Additionally, it exhibits antioxidant, anti-inflammatory, analgesic, and anxiolytic activities.

GHK also improves stem cell functionality by promoting cellular “stemness” and the secretion of trophic factors from mesenchymal stem cells. Computational studies using the Broad Institute’s Connectivity Map (cMap) indicate that GHK can broadly reset abnormal gene-expression patterns toward a healthier state, highlighting its potential therapeutic importance across age-related conditions.

GHK Reverses COPD-Related Gene Expression Patterns

In 2012, Campbell and colleagues used the cMap platform to identify gene targets relevant to chronic obstructive pulmonary disease (COPD). COPD, encompassing emphysema and chronic bronchitis, progressively limits airflow and causes substantial loss of lung function. They identified 127 genes whose expression was correlated with regional severity of emphysema.

The cMap algorithm predicted that GHK could reverse the disease-associated expression profile and promote a reparative genetic program. Laboratory studies confirmed these predictions: treatment with 10 nM GHK in fibroblasts derived from diseased lung tissue altered expression patterns from destructive toward reparative. This was associated with actin cytoskeleton reorganization, increased integrin beta-1 expression, and restored collagen contractility. These findings indicate that GHK can potentially reprogram COPD-affected cells to restore tissue structure and function.

GHK Provides Analgesic and Anxiolytic Benefits

Chronic anxiety and pain frequently complicate neurodegenerative conditions and dementia. Interestingly, peptides that interact with the opiate system often share analgesic and wound-healing functions. In one nutritional study, men placed on a copper-deficient diet (1 mg/day) for 11 weeks exhibited an 80% reduction in plasma opiate levels. When dietary copper intake was normalized (3 mg/day), opiate levels recovered.

Animal studies demonstrate that GHK has both analgesic and anxiolytic effects. In rodent models, a dose of 0.5 mg/kg reduced thermal injury pain. Within 12 minutes of intraperitoneal injection, treated animals showed increased exploration of open maze areas and reduced immobility — behaviors indicating decreased anxiety and fear. Remarkably, similar anxiolytic and anti-pain responses were observed at microgram-level doses (0.5 µg/kg).

GHK as a Broad Antioxidant and Neuroprotective Agent

GHK possesses potent antioxidant activity in mammalian systems and cultured cells. Beyond direct scavenging effects, it upregulates genes associated with antioxidant defense. Oxidative stress is implicated in the progression of neurodegenerative disorders such as Parkinson’s disease, suggesting that GHK’s antioxidant activity may confer neuroprotective benefits.

GHK Stimulates DNA Repair and Growth Factor Production After Radiation

Radiation therapy damages DNA and suppresses cellular replication. In fibroblast cultures from patients exposed to radiation therapy for head and neck cancer, cell division rates were slowed. However, treatment with nanomolar concentrations of GHK-Cu restored normal doubling times. Irradiated cells treated with GHK-Cu also secreted higher levels of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF), both critical for repair and regeneration.

Genomic analyses reveal that GHK primarily stimulates DNA repair-related gene expression, with 47 genes upregulated and only 5 suppressed, strongly suggesting enhanced DNA repair activity.

GHK Boosts the Ubiquitin-Proteasome System for Protein Clearance

The ubiquitin-proteasome system (UPS) is responsible for degrading damaged and misfolded proteins. Age-related decline in UPS activity contributes to the accumulation of toxic protein oligomers that can initiate neurodegenerative cascades. To date, no therapies have been successfully developed to specifically boost UPS activity.

GHK significantly upregulates the expression of UPS-associated genes — 41 genes increased, with only 1 suppressed — highlighting its potential role in maintaining proteostasis and preventing neurodegenerative processes driven by impaired protein clearance.

REFERENCE

Pickart L, Vasquez-Soltero JM, Margolina A. The Effect of the Human Peptide GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline. Brain Sci. 2017 Feb 15;7(2):20. doi: 10.3390/brainsci7020020. PMID: 28212278; PMCID: PMC5332963.

Product available for research use only: